Background: T1 mapping can quantify the longitudinal relaxation time of tissues. This study aimed to investigate the repeatability and reproducibility of T1 mapping radiomics features of lung cancer and the feasibility of T1 mapping-based radiomics model to predict its pathological types.
Methods: The chest T1 mapping images and clinical characteristics of 112 lung cancer patients (54 with adenocarcinoma and 58 with other types of lung cancer) were collected retrospectively. 54 patients underwent twice short-term T1 mapping scans. Regions of interest were manually delineated on T1 mapping pseudo-color images to measure the mean native T1 values of lung cancer, and radiomics features were extracted using the semi-automatic segmentation method by two independent observers. The patients were randomly divided into training group (77 cases) and validation group (35 cases) with the ratio of 7:3. Interclass correlation coefficients (ICCs), Student's t-test or Mann-Whitney U tests and least absolute shrinkage and selection operator (LASSO) were used for feature selection. The optimum features were selected to establish a logistic regression (LR) radiomics model. Independent sample t-test, Mann Whitney U-test or chi square test were used to compare the differences of clinical characteristics and T1 values. Performance was compared by the area under the receiver operating characteristic (ROC) curve (AUC).
Results: In the training group, smoking history, lesion type and native T1 values were different between adenocarcinoma and non-adenocarcinoma patients (P = 0.004-0.038). There were 1035 (54.30%) radiomics features meet the intra-and inter-observer, and test-retest reproducibility with ICC > 0.80. After feature dimensionality reduction and model construction, the AUC of T1 mapping-based radiomics model for predicting the pathological types of lung cancer was 0.833 and 0.843, respectively, in the training and validation cohorts. The AUCs of T1 value and clinical model (including smoking history and lesion type) were 0.657 and 0.692 in the training group, and 0.722 and 0.686 in the validation group. Combined with T1 mapping radiomics, clinical model and T1 value to establish a combined model, the prediction efficiency was further improved to 0.895 and 0.915 in the training and validation groups.
Conclusions: About 50% of the T1 mapping-based radiomics features displayed relatively poor repeatability and reproducibility. While T1 mapping-based radiomics model is valuable in identification of histological types of lung cancer despite the measurement variability. Combination of T1 mapping radiomics model, clinical characteristics and native T1 value can improve the predictive value of pathological types of lung cancer.
Keywords: Adenocarcinoma; Lung cancer; Pathology; Radiomics; T1 mapping.
© 2024. The Author(s).